Blueshift Asset Management, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1727827 RED BANK, NJ

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$637,581

+$323,040 QoQ

Shares Held

2,118

+167.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#456

of 784 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Blueshift Asset Management, LLC holds $9,217,770 across 26 Biotechnology names. ALNY ranks #4 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,843	$1,149,184
2	ROIV	Roivant Sciences Ltd.	30,383	$1,075,254
3	AXSM	Axsome Therapeutics, Inc.	2,834	$693,678
4	ALNY	Alnylam Pharmaceuticals, Inc. This page	2,118	$637,581
5	APGE	Apogee Therapeutics, Inc.	4,209	$558,660
6	INSM	INSMED Inc	4,800	$511,776
7	BMRN	Biomarin Pharmaceutical Inc	8,143	$465,942
8	ARWR	Arrowhead Pharmaceuticals, Inc.	4,819	$392,796

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$637,581	2,118	+167.8%	Shares	Sole	2026-08-14
2025-12-31	$314,541	791	+31.2%	Shares	Sole	2026-02-13
2025-09-30	$274,968	603	-64.5%	Shares	Sole	2025-11-13
2024-12-31	$399,556	1,698	+59.1%	Shares	Sole	2025-02-11
2024-09-30	$293,457	1,067	-71.6%	Shares	Sole	2024-11-13
2023-06-30	$714,744	3,763	-31.7%	Shares	Sole	2023-08-15
2022-03-31	$899,074	5,506	-3.4%	Shares	Sole	2022-05-12
2021-12-31	$966,945	5,702	+66.4%	Shares	Sole	2022-02-11
2021-09-30	$646,863	3,426	-46.9%	Shares	Sole	2021-11-12
2021-03-31	$910,251	6,447	+137.3%	Shares	Sole	2021-05-06
2020-12-31	$353,128	2,717	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.